Cognition Therapeutics announced that CEO Lisa Ricciardi will participate in the 2026 Jefferies Global Healthcare Conference in London to discuss the company's recent FDA meeting about finalizing endpoints for the Phase 3 trial of their dementia drug zervimesine. This drug targets dementia with Lewy bodies and has shown promise in Phase 2 trials for neurodegenerative diseases including Alzheimer's. The company aims to advance zervimesine into a registrational trial for patients with dementia-related psychosis. Investors can arrange one-on-one meetings with the CEO during the conference.
Cognition Therapeutics' participation in the 2026 Jefferies Global Healthcare Conference provides context for healthcare sector activity on Pluang. For readers following healthcare stocks, here is Pluang's market snapshot as of Nov 09, 2026 18:41 WIB: Among 150 priced US health-sector stocks, 108 rose and 26 fell today. ClearPoint Neuro Inc (CLPT) gained 4.53% to USD 8.99 with a typical hold time of 12 days, contrasting with Abeona Therapeutics Inc (ABEO), which dropped 4.32% to USD 3.99 and has a longer typical hold time of 28 days. Roivant Sciences Ltd. (ROIV) also rose 3.88% to USD 40.39, with a typical hold time of 15 days.
Microsoft will retire the backend services for its UWP Map Control and Windows Maps APIs on November 30, 2026, ending map functionality in many Windows desktop and tablet applications. OnTerra Systems, a Microsoft partner, has developed an off-the-sh...
Marengo Therapeutics presented interim Phase 2 results from the STARt-002 trial combining invikafusp alfa, a selective T-cell agonist, with sacituzumab govitecan in metastatic triple-negative and HR-positive/HER2-negative breast cancer. The trial sho...
Holzer & Holzer, LLC announced deadlines for investors to seek lead plaintiff status in shareholder class action lawsuits against The Ensign Group, Netcapital Inc., and Webull Corporation. These lawsuits allege misleading statements and failure to di...
Octave Intelligence plc has introduced Octave Attune Facilities, a cloud-based software solution designed to help organizations manage multiple sites with AI-powered tools. This platform integrates building, space, maintenance, and operational data t...
ITT Inc. reported a strong third quarter with revenue up 44% to over $1.40 billion and adjusted earnings rising 20% to $2.26 per share, driven by the SPX FLOW acquisition and 8% organic growth. Orders surged 58%, supported by aerospace, defense, and ...
